Abstract
Idiotypic determinants of the immunoglobuiin expressed on the surface of B–cell lymphomas are tumor–specific antigens (TSAs), which can be targeted by immunotherapy. Immunization with DNA constructs encoding the idiotype (Id) of a murine B–cell lymphoma induced specific anti–Id antibody responses and protected mice against tumor challenge. Use of DNA encoding an Id/GM–CSF (idiotype/granulocyte–macrophage colony–stimulating factor) fusion protein improved vaccine efficacy, and xenogeneic immunoglobuiin constant region determinants were required for immunogenicity. These results indicate that DNA may be a simple and efficacious means of inducing immune responses against a weak, otherwise unrecognized tumor antigen, provided that additional stimuli are included with the DNA.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kaminski, M.S., Kitamura, K., Maloney, D.G. & Levy, R. Idiotype vaccination against murine B cell lymphoma: Inhibition of tumor immunity by free idiotype protein. J. Immunol. 38, 1289–1296 (1987).
George, A.J., Folkard, S.G., Hamblin, T.J. & Stevenson, F.K. Idiotypic vaccination as a treatment for a B cell lymphoma. J. Immunol. 141, 2168–2174 (1988).
Tao, M.H. & Levy, R. IdiotypeJgranulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature 362, 755–758 (1993).
Kwak, L.W. et al. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N. Engl. J. Med. 327, 1209–1215 (1992).
Hawkins, R.E. et al. Idiotypic vaccination against human B-cell lymphoma: Rescue of variable region gene sequences from biopsy material for assembly as single-chain Fv personal vaccines. Blood 83, 3279–3288 (1994).
Watanabe, A. et al. Induction of antibodies to a kappa V region by gene immunization. J. Immunol. 151, 2871–2876 (1993).
Hawkins, R.E., Winter, G., Hamblin, T.J., Stevenson, F.K. & SJ.A genetic approach to idiotypic vaccination. J. Immunother. 14, 273–278 (1993).
Stevenson, F.K. et al. Idiotypic DNA vaccines against B-cell lymphoma. Immunol. Rev. 145, 211–228 (1995).
Ulmer, J.B. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745–1749 (1993).
Xiang, Z.Q. et al. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199, 132–140 (1994).
Sedegah, M., Hedstrom, R., Hobart, P. & Hoffman, S.L. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91, 9866–9870 (1994).
Irvine, K.R., Rao, J.B., Rosenberg, S.A. & Restifo, N.P. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J. Immunol. 156, 238–245 (1996).
Bergman, Y. & Haimovich, J. Characterization of a carcinogen-induced murine B lymphocyte cell line of C3HJeB origin. Eur. J. Immunol. 7, 413–317 (1977).
Chen, T.T., Tao, M.H. & Levy, R. Idiotype-cytokine fusion proteins as cancer vaccines: Relative efficacy of IL-2, IL-4, and granulocyte-macrophage colony-stimulating factor. J. Immunol. 153, 4775–4787 (1994).
Slavin, S. & Strober, S. Spontaneous murine B-cell leukemia. Nature 272, 624–626 (1978).
Germain, R.N. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation. Cell 76, 287–299 (1994).
Xiang, Z. & Ertl, H.C. Manipulation of the immune response to a plasmid encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2, 129–135 (1995).
Fynan, E.F. et al. DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Set USA 90, 11478–11482 (1993).
Raz, E. et al. Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA 91, 9519–9523 (1994).
Stevens, T.L. et al. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334, 255–258 (1988).
Reitan, S.K. & Hannestad, K. A syngeneic idiotype is immunogenic when borne by IgM but tolerogenic when joined to IgG. Eur. J. Immunol 25, 1601–1608 (1995).
Chen, T.T. & Levy, R. Induction of autoantibody responses to GM-CSF by hyperimmunization with an Id-GM-CSF fusion protein. J. Immunol. 154, 3105–3117(1995).
Reff, M.E. et al. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83, 435–445 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Syrengelas, A., Chen, T. & Levy, R. DNA immunization induces protective immunity against B–cell lymphoma. Nat Med 2, 1038–1041 (1996). https://doi.org/10.1038/nm0996-1038
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0996-1038
This article is cited by
-
Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol
BMC Cancer (2018)
-
Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine
Cancer Immunology, Immunotherapy (2011)
-
Therapeutic vaccines for non-Hodgkin B-cell lymphoma
Clinical and Translational Oncology (2008)
-
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models
BMC Biotechnology (2007)
-
BCL1 lymphoma protection induced by idiotype DNA vaccination is entirely dependent on anti-idiotypic antibodies
Cancer Immunology, Immunotherapy (2005)